FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-5934fje.
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-5934fjev1
20/10/1751    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mainieri, D.
Right arrow Articles by Dulloo, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mainieri, D.
Right arrow Articles by Dulloo, A. G.
(The FASEB Journal. 2006;20:1751-1753.)
© 2006 FASEB

A role for skeletal muscle stearoyl-CoA desaturase 1 in control of thermogenesis

Davide Mainieri*, Serge Summermatter*, Josiane Seydoux*, Jean-Pierre Montani*, Sandro Rusconi{dagger}, Aaron P. Russell{ddagger}, Olivier Boss§, Antony J. Buchala|| and Abdul G. Dulloo*,1

Division of

* Physiology and

{dagger} Biochemistry, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland;

{ddagger} Clinique de réadaptation, SUVA Care, Sion, Switzerland;

§ Endocrinology of Energy Metabolism, Boston, Massachusetts, USA; and

|| Department of Biology, Faculty of Science, University of Fribourg, Fribourg, Switzerland

1Correspondence: Division of Physiology, Department of Medicine, University of Fribourg, Chemin du Musée 5, CH-1700 Fribourg, Switzerland. E-mail: abdul.dulloo{at}unifr.ch

SPECIFIC AIMS

An enhanced metabolic efficiency for accelerating the recovery of fat mass (or catch-up fat) is a characteristic feature of body weight regulation after weight loss or growth retardation. It is viewed as the outcome of an "adipose-specific" suppression of thermogenesis, i.e., a feedback control system in which signals from the depleted adipose fat stores exert a suppressive effect on skeletal muscle thermogenesis to conserve energy in favor of catch-up fat. To elucidate the effector system of this adipose-specific suppression of thermogenesis, our specific aims were 1) to identify genes the altered expression of which in skeletal muscle during semistarvation would persist during refeeding in parallel to the suppressed thermogenesis that favors catch-up fat and 2) to validate the impact of altered expression of such gene(s) on skeletal muscle metabolism during both semistarvation and refeeding.

PRINCIPAL FINDINGS

1. Screening of candidate genes reveals stearoyl-coenzyme A desaturase 1
Using a rat model of semistarvation-refeeding in which catch-up fat results from suppressed thermogenesis per se (Fig. 1 ), we first screened and validated, by quantitative RT-polymerase chain reaction (PCR), three sets of candidate genes for an expression profile of persistent up-regulation or down-regulation in skeletal muscle on day 7 of refeeding (i.e., at RF-7) after 2 wk of semistarvation (i.e., at RF-0). These three sets of candidate genes were as follows: 1) genes identified for showing this pattern of expression by the technique of differential display followed by microarray analysis, notably genes that code for muscle-specific proteins related to structure/contraction (myosins and collagen); 2) genes that are involved in calcium cycling (SERCA1, SERCA 2a, and sarcolipin) and that are known to be regulated by thyroid hormones; and 3) genes the deletion or overexpression of which, by gene manipulation technology in muscle cell systems or in generating transgenic mice, have been reported to result either in altered thermogenesis [PGC-1{alpha} mitofusin2, IL6, DGAT1, and stearoyl-coenzyme A desaturase 1 (SCD1)] or in an altered gene profile, which is consistent with ßbeta;-adrenergic control of thermogenesis (Nur77).


Figure 1
View larger version (11K):
[in this window]
[in a new window]
 
Figure 1. Study design for screening and validating candidate skeletal muscle genes implicated in the adipose-specific suppression of thermogenesis using a previously described rat model of semistarvation-refeeding in which the accelerated fat recovery (catch-up fat) results only from suppressed thermogenesis, i.e., not from confounding effects of hyperphagia or lower lean body mass or protein mass. In this particular study in 6-wk-old male Sprague-Dawley rats at start of study, energy balance and body composition measurements were determined over 3 successive periods of 1 wk each during course of refeeding and comparisons made with controls matched for weight at onset of refeeding. Acceleration of fat deposition but not that of protein deposition (i.e., preferential catch-up fat) is attributed to diminished energy expenditure (suppressed thermogenesis) that lasts for {approx}2 wk. Skeletal muscle was harvested, namely at end of 2 wk semistarvation period, i.e., at onset of refeeding (RF-0) and after 1 wk of refeeding (RF-7). All values are means and SE. (n=6); **P < 0.01; ***P < 0.001.

In the overall analysis of these data, SCD1, an enzyme that catalyzes the synthesis of monounsaturated fatty acids (MUFAs) by introducing a double bond at the {Delta}9 position of saturated fatty acids (SFA), was found to be the only translated gene that showed a pattern of expression that consistently correlated with a persistent suppression of thermogenesis directed at catch-up fat during refeeding after semistarvation.

2. Muscle-specificity in SCD1 gene up-regulation and hormonal regulation
The SCD1 transcript in skeletal muscle showed a robust elevation in mRNA levels of 2- to 4-fold relative to controls, both after 2 wk of semistarvation and after 1 wk of refeeding (Fig. 2 ). These elevations in the SCD1 transcript are skeletal muscle specific, since they do not occur in liver or in adipose tissue. An examination of the pattern of changes in hormones that are capable of stimulating skeletal muscle thermogenesis and repressing SCD1, namely leptin, thyroid hormones, and possibly also catecholamines, revealed that at least two of them are lower than in controls during semistarvation (leptin, T3, and T4) or during subsequent refeeding (T3 and epinephrine) in parallel to the phase of suppressed thermogenesis that favors catch-up fat.


Figure 2
View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Muscle-specific increases in mRNA levels of SCD1 (normalized to that of cyclophilin) after 2 wk of semistarvation in food-restricted (R0) and control (C0) animals, as well as after 1 wk of controlled refeeding in refed (R7) and control (C7) animals. All values are means and SE. (n=6); *P < 0.05; **P < 0.01.

3. Indices of increased muscle SCD1 activity
The functional relevance of these elevations in the SCD1 transcript to skeletal muscle lipid metabolism during semistarvation and refeeding is underlined by the results of subsequent analysis of microsomal and lipid fractions extracted from these muscles. These indicate parallel elevations in several indices of SCD1 enzyme activity both during semistarvation and refeeding, namely: 1) an increase in the {Delta}9 desaturase activity measured in the microsomal fractions; 2) an increase in the relative content of SCD1-derived MUFA, palmitoleolyl-coenzyme A (C16:1) and oleoyl-coenzyme A (C18:1), in several of the following lipid fractions: monoglycerides (MG), diglycerides (DG), triglycerides (TG), and phospholipids (PL); and 3) an increase in the {Delta}9 desaturation index that relates substrate and product in the reaction catalyzed by SCD1, namely palmitoyl-coenzyme A (C16:0) and stearoyl-coenzyme A (C18:0) as substrates, and palmitoleolyl-coenzyme A (C16:1) and oleoyl-coenzyme A (C18:1) as products. The {Delta}9 desaturation index is calculated as the ratio of C18:1/C18:0 or C16:1/C16:0 in each lipid fraction, using the quantitated values for palmitate (16:0), palmitoleate (16:1), stearate (18:0), and oleate (18:1) determined by gas chromatography/mass spectrometry.

These data reveal similarities, but also striking differences, in the changes in skeletal muscle lipid composition during semistarvation as opposed to those observed during refeeding. Whereas the elevations in the muscle {Delta}9 desaturation index and/or in the relative proportion of the SCD1-derived-MUFA were found in the MG and DG fractions both in response to semistarvation and to refeeding, they were only observed in the TG fraction in response to semistarvation and only in the PL fraction in response to refeeding.

CONCLUSIONS AND SIGNIFICANCE

The precise mechanisms by which these elevations in SCD1 activity and differential flux of SCD1-derived MUFA toward stored lipids (during semistarvation) or toward membrane lipids (during refeeding) might lead to suppressed thermogenesis in skeletal muscle are unknown. A common function of desaturases in organisms is to maintain the physical property of stored triglycerides and membrane lipids. One possible explanation therefore is that SCD1, by regulating the fatty acid composition of stored lipids and/or membrane phospholipids, induces modifications in lipid signaling molecules and/or membrane fatty acid composition that might alter the activities of multiple regulatory enzymes and proteins that are involved in the cellular effector system that mediates thermogenesis. Of particular relevance in this context are the findings that the enhanced thermogenesis in mice lacking SCD1 can be associated with increases in the activities of skeletal muscle phosphatidylinositol-3 kinase and AMP-activated protein kinase, two signaling pathways that have been shown to be required for hormonal stimulation of skeletal muscle thermogenesis through their actions in orchestrating substrate cycling between de novo lipogenesis and lipid oxidation. An alternative explanation is based on evidence that MUFA are much less potent than SFA as inhibitors of acetyl-coenzyme A carboxylase, the enzyme that catalyzes the synthesis of malonyl coenzyme A, the immediate precursor for de novo synthesis of fatty acids. The possibility therefore arises that SCD1 up-regulation, by increasing the conversion of de novo synthesized SFA to MUFA, would lead to diminished feedback inhibition of de novo synthesized fatty acids in the formation of their precursor substrate malonyl coenzyme A, which is also an inhibitor of mitochondrial CPT1 shuttle system that controls import and oxidation of fatty acids in mitochondria. Thus, as depicted in the biochemical model presented in Fig. 3 , by enhancing the conversion of the products of de novo lipogenesis to MUFA, an elevated SCD1 would divert de novo synthesized SFA and its MUFA products away from pathways of lipid ßbeta;-oxidation and effectively shut down this energy-dissipating substrate cycle, thereby leading to energy conservation. This model takes into account the differential effects of SCD1 up-regulation during semistarvation and refeeding, namely with the SCD1-derived MUFA being channeled, via the MG and DG intermediates of lipid metabolism, toward storage lipids (TG) during semistarvation, as opposed to being channeled toward membrane lipids (PL) during refeeding.


Figure 3
View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Model illustrating the mechanisms by which an up-regulation of SCD1 in skeletal muscle might lead to suppressed thermogenesis. In fed state (A), repeated recycling of acetyl-coenzyme A through flux of substrates across de novo lipogenesis followed by mitochondrial ßbeta;-oxidation constitutes an energy dissipating "substrate cycling" in skeletal muscle. During semistarvation and early refeeding (B), an elevated SCD1 would, by enhancing the desaturation of de novo synthesized fatty acids, divert them away from pathways of mitochondrial ßbeta;-oxidation and effectively shut down this thermogenic substrate cycling mechanism, thereby leading to energy conservation.

In recent years, SCD1 has been proposed as a target for the treatment of obesity and the metabolic syndrome after the demonstrations that its disruption in mice leads to enhanced thermogenesis, which confers resistance to obesity and its comorbidities. Our findings here implicating a physiological role for skeletal muscle SCD1 up-regulation in the adaptive suppression of thermogenesis that regulates body fat stores therefore provide a physiological rationale for targeting skeletal muscle SCD1 or its lipid product moieties both in the management of obesity, as well as in counteracting the preferential catch-up fat phenotype that contributes to the pathophysiological consequences of rapid catch-up growth.

FOOTNOTES

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.06-5934fje




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Kus, T. Prazak, P. Brauner, M. Hensler, O. Kuda, P. Flachs, P. Janovska, D. Medrikova, M. Rossmeisl, Z. Jilkova, et al.
Induction of muscle thermogenesis by high-fat diet in mice: association with obesity-resistance
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E356 - E367.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Summermatter, D. Mainieri, A. P. Russell, J. Seydoux, J. P. Montani, A. Buchala, G. Solinas, and A. G. Dulloo
Thrifty metabolism that favors fat storage after caloric restriction: a role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase
FASEB J, March 1, 2008; 22(3): 774 - 785.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-5934fjev1
20/10/1751    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mainieri, D.
Right arrow Articles by Dulloo, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mainieri, D.
Right arrow Articles by Dulloo, A. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.